113 related articles for article (PubMed ID: 12614895)
1. Bis-4-aminoquinolines: novel triple-helix DNA intercalators and antagonists of immunostimulatory CpG-oligodeoxynucleotides.
Strekowski L; Say M; Zegrocka O; Tanious FA; Wilson WD; Manzel L; Macfarlane DE
Bioorg Med Chem; 2003 Mar; 11(6):1079-85. PubMed ID: 12614895
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by 4-aminoquinolines and other weak bases: mechanistic studies.
Manzel L; Strekowski L; Ismail FM; Smith JC; Macfarlane DE
J Pharmacol Exp Ther; 1999 Dec; 291(3):1337-47. PubMed ID: 10565859
[TBL] [Abstract][Full Text] [Related]
3. Fujita-Ban QSAR analysis and CoMFA study of quinoline antagonists of immunostimulatory CpG-oligodeoxynucleotides.
Paliakov E; Henary M; Say M; Patterson SE; Parker A; Manzel L; Macfarlane DE; Bojarski AJ; Strekowski L
Bioorg Med Chem; 2007 Jan; 15(1):324-32. PubMed ID: 17049254
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds.
Macfarlane DE; Manzel L
J Immunol; 1998 Feb; 160(3):1122-31. PubMed ID: 9570525
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship analysis of substituted 4-quinolinamines, antagonists of immunostimulatory CpG-oligodeoxynucleotides.
Strekowski L; Zegrocka O; Henary M; Say M; Mokrosz MJ; Kotecka BM; Manzel L; Macfarlane DE
Bioorg Med Chem Lett; 1999 Jul; 9(13):1819-24. PubMed ID: 10406648
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and activity of substituted 2-phenylquinolin-4-amines, antagonists of immunostimulatory CpG-oligodeoxynucleotides.
Strekowski L; Say M; Henary M; Ruiz P; Manzel L; Macfarlane DE; Bojarski AJ
J Med Chem; 2003 Mar; 46(7):1242-9. PubMed ID: 12646034
[TBL] [Abstract][Full Text] [Related]
7. Requirement of nucleobase proximal to CpG dinucleotide for immunostimulatory activity of synthetic CpG DNA.
Yu D; Kandimalla ER; Zhao Q; Bhagat L; Cong Y; Agrawal S
Bioorg Med Chem; 2003 Feb; 11(3):459-64. PubMed ID: 12517441
[TBL] [Abstract][Full Text] [Related]
8. Alternate-strand triple-helix formation by the 3'-3'-linked oligodeoxynucleotides with the intercalators at the junction point.
Ueno Y; Mikawa M; Hoshika S; Takeba M; Kitade Y; Matsuda A
Nucleic Acids Res Suppl; 2001; (1):11-2. PubMed ID: 12836239
[TBL] [Abstract][Full Text] [Related]
9. Bis-pyridoquinolines as new bifunctional intercalators for DNA.
Malesani G; Chiarelotto G; Ferlin MG; Bordin F; Baccichetti F; Carlassare F; Vedaldi D; Dall'Acqua F
Farmaco Sci; 1984 Nov; 39(11):925-34. PubMed ID: 6519263
[TBL] [Abstract][Full Text] [Related]
10. Linkage structures strongly influence the binding cooperativity of DNA intercalators conjugated to triplex forming oligonucleotides.
Orson FM; Kinsey BM; McShan WM
Nucleic Acids Res; 1994 Feb; 22(3):479-84. PubMed ID: 8127688
[TBL] [Abstract][Full Text] [Related]
11. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells.
Kerkmann M; Rothenfusser S; Hornung V; Towarowski A; Wagner M; Sarris A; Giese T; Endres S; Hartmann G
J Immunol; 2003 May; 170(9):4465-74. PubMed ID: 12707322
[TBL] [Abstract][Full Text] [Related]
12. Structural and immunostimulatory properties of Y-shaped DNA consisting of phosphodiester and phosphorothioate oligodeoxynucleotides.
Matsuoka N; Nishikawa M; Mohri K; Rattanakiat S; Takakura Y
J Control Release; 2010 Dec; 148(3):311-6. PubMed ID: 20887761
[TBL] [Abstract][Full Text] [Related]
13. The binding of CpG-oligodeoxynucleotides to cell-surface and its immunostimulatory activity are modulated by extracellular acidic pH.
Hu Z; Sun S; Zhou F
Vaccine; 2003 Jan; 21(5-6):485-90. PubMed ID: 12531648
[TBL] [Abstract][Full Text] [Related]
14. Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells.
Britigan BE; Lewis TS; Waldschmidt M; McCormick ML; Krieg AM
J Immunol; 2001 Sep; 167(5):2921-8. PubMed ID: 11509640
[TBL] [Abstract][Full Text] [Related]
15. Alpha-beta chimeric oligo-DNA bearing intercalator-conjugated nucleobase inside the linker sequence remarkably improves thermal stability of an alternate-stranded triple helix.
Zafrul Azam AT; Hasegawa M; Moriguchi T; Shinozuka K
Bioorg Med Chem Lett; 2004 Dec; 14(23):5747-50. PubMed ID: 15501034
[TBL] [Abstract][Full Text] [Related]
16. The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides.
Weiner GJ
J Leukoc Biol; 2000 Oct; 68(4):455-63. PubMed ID: 11037965
[TBL] [Abstract][Full Text] [Related]
17. Nanodelivery systems for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides.
Zhang H; Gao XD
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 2):935-946. PubMed ID: 27772724
[TBL] [Abstract][Full Text] [Related]
18. Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides.
Yu C; An M; Li M; Liu H
Mol Pharm; 2017 Aug; 14(8):2815-2823. PubMed ID: 28686452
[TBL] [Abstract][Full Text] [Related]
19. Uptake, intracellular distribution, and novel binding proteins of immunostimulatory CpG oligodeoxynucleotides in microglial cells.
Zhang Z; Weinschenk T; Schluesener HJ
J Neuroimmunol; 2005 Mar; 160(1-2):32-40. PubMed ID: 15710455
[TBL] [Abstract][Full Text] [Related]
20. Novel immunostimulatory agent based on CpG oligodeoxynucleotide linked to the nontoxic B subunit of cholera toxin.
Adamsson J; Lindblad M; Lundqvist A; Kelly D; Holmgren J; Harandi AM
J Immunol; 2006 Apr; 176(8):4902-13. PubMed ID: 16585586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
